发明名称 MCP-1 BINDING NUCLEIC ACID AND USING IT
摘要 FIELD: medicine, pharmaceutics.SUBSTANCE: group of inventions refers to biotechnology and medicine. Administering into an individual a nucleic acid molecule, which is able to bind to MCP-1 and is an MCP-1 antagonist, wherein the nucleic acid molecule contains the nucleic acid sequence SEQ ID NO:37 in a combination with an immunosuppressive agent, for treating lupus nephritis enables reducing a dose of the immunosuppressive agent.EFFECT: administering into the individual the nucleic acid molecule, wherein the nucleic acid molecule contains the nucleic acid sequence SEQ ID NO:37 has a therapeutic effect in treating pulmonary hypertension and chronic obstructive pulmonary disease.30 cl, 54 dwg, 1 tbl, 12 ex
申请公布号 RU2542973(C2) 申请公布日期 2015.02.27
申请号 RU20100126662 申请日期 2008.11.29
申请人 NOKSON FARMA AG 发明人 PURSHKE, VERNER;JAROSH, FLORIAN;OJLBERG, DIRK;KLUSSMANN, SVEN;BUKHNER, KLAUS;MAASH, KRISTIAN
分类号 A61K31/7088;A61P11/00;A61P13/12;C12N15/115 主分类号 A61K31/7088
代理机构 代理人
主权项
地址